Legend Biotech (LEGN) Superinvestor holders
11 of the superinvestors we track hold Legend Biotech (LEGN) in their latest 13F filings, $386M in total.
Summary
The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $173M, 20.8% of the portfolio.
In their latest quarter: 1 opened a new position, 3 added, 6 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Zhang Lei Hillhouse (HHLR Advisors) |
Held | 5,984,550 | $173M | 20.8% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 3,076,124 | $89M | 0.1% | Q2 2026 |
| Artisan Partners | Trimmed | 1,559,441 | $45M | 0.1% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 1,000,200 | $29M | 0.0% | Q2 2026 |
| Arrowstreet Capital | Added | 759,994 | $22M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 795,716 | $16M | 0.0% | Q3 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 202,227 | $6M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 163,903 | $5M | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
New position | 46,856 | $1M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 29,066 | $839,426 | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 3,300 | $95,304 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 11 |
| Q1 2026 | 11 |
| Q4 2025 | 11 |
| Q3 2025 | 8 |
| Q2 2025 | 9 |
| Q1 2025 | 8 |
| Q4 2024 | 7 |
| Q3 2024 | 10 |
Questions about Legend Biotech
Which superinvestors own Legend Biotech?
11 of the superinvestors we track hold Legend Biotech (LEGN) in their latest 13F filings, $386M in total. Zhang Lei, Steve Cohen, Artisan Partners, Jim Simons, Arrowstreet Capital, Acadian.
Who is the largest superinvestor holder of LEGN?
The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $173M, 20.8% of the portfolio.
From Legend Biotech's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.